Dithranol therapy in childhood psoriasis: Unjustifiably on the verge of falling into oblivion

Dermatology

Volumn 220, Issue 4, 2010, Pages 329-332

  De Jager, M E A ^a   Van De Kerkhof, P C M ^a   De Jong, E M G J ^a   Seyger, M M B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Childhood; Dithranol; Efficacy; Psoriasis; Safety; Treatment

Indexed keywords

CORTICOSTEROID; DITHRANOL; SALICYLIC ACID; VITAMIN D DERIVATIVE; DERMATOLOGICAL AGENT; VITAMIN D;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; DRUG EFFICACY; DRUG SAFETY; HUMAN; MAJOR CLINICAL STUDY; PHOTOTHERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PSORIASIS; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN IRRITATION; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANALOGS AND DERIVATIVES; DRUG ADMINISTRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ANTHRALIN; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; HUMANS; PSORIASIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; ULTRAVIOLET THERAPY; VITAMIN D;

EID: 77954241942     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000278241     Document Type: Article

References (11)

1. Galewski E: Über Cignolin, ein Ersatzpräparat des Chrysarobins. Dermatol Wochenschr 1916; 6: 113-115.
2. Ashton RE, André P, Lowe NJ, Whitefield M: Anthralin: historical and current perspectives. J Am Acad Dermatol 1983; 9: 173-192. (Pubitemid 13078766)
3. van de Kerkhof PC, Barker J, Griffiths CE, Kragballe K, Mason J, Menter A, Papp K: Psoriasis: consensus on topical therapies. J Eur Acad Dermatol Venereol 2008; 22: 859-870.
4. Zvulunov A, Anisfeld A, Metzker A: Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol 1994; 33: 808-810.
5. Guerrier CJ, Porter DI: An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children. Curr Med Res Opin 1983; 8: 446-450.
6. Christensen OB, Holst R, Hradil E, Brolund L: Clinical response and side effects in the treatment of psoriasis with UV-B and-A novel dithranol formulation. Acta Derm Venereol Suppl (Stockh) 1989; 146: 96-100.
7. Duschet P, Schwarz T, Pusch M, Wagner A, Gschnait F: Anthralin minute entire skin treatment: a follow-up and comparison with methoxsalen plus ultraviolet light. Arch Dermatol 1987; 123: 428-429.
8. Schwarz T, Gschnait F: Anthralin minute entire skin treatment: a new outpatient therapy for psoriasis. Arch Dermatol 1985; 121: 1512-1515.
9. van de Kerkhof PC: Dithranol treatment in psoriasis: after 75 years, still going strong. Eur J Dermatol 1991; 1: 79-88.
10. de Jager ME, de Jong EM, van de Kerkhof PC, Seyger MM: Efficacy and safety of treatments for childhood psoriasis: a systematic literature review. J Am Acad Dermatol 2009, E-pub ahead of print.
11. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, van Voorhees AS, Beutner KR, Bhushan R: Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010; 62: 114-135.